Loading clinical trials...

Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture) | Clinical Trials | Clareo Health

COMPLETEDPHASE2

Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)

NCT00535717•Maharashtra University of Health Sciences

Summary

Uttarbasti is per urethral administration of medicated oil which has been recommended by Sushrut for urinary track disorders. As far as conventional surgery is concerned urethral stricture still remains a challenge due to post procedural high recurrences and complications Uttarbasti being almost non invasive, with minimum recurrences and most economical, easy to practice OPD procedure, can be the treatment of choice in the management of urethral stricture.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•K/C/O Urethral Stricture of either sex and from all age groups.

Exclusion Criteria

•With acute UTI.
•DM.
•Neoplasms of lower urinary tract
•BEP.
•With impacted calculus in urethra and bladder neck.

Key Dates

Last Updated

September 26, 2007

Conditions

Urethral Stricture

Interventions

uttarbasti (per urethral administration of medicated oil )

PROCEDURE

Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon

NCT06795074

Urethral Stricture

View study

RECRUITINGPHASE4

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

NCT05383274

Urethral Stricture

View study

ACTIVE_NOT_RECRUITING

Optilume Registry for Treatment of Stricture of the Anterior Urethra

NCT05479422

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 26, 2007Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)

Inclusion Criteria

Exclusion Criteria

Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Optilume Registry for Treatment of Stricture of the Anterior Urethra

Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

Vessel-sparing Technique Versus Conventional Repair of PFUI: A Prospective Comparative Study

Comparison Between Two Techniques Used in Treatment of Long Anterior Urethral Stricture